Seminars in Diagnostic Pathology

Papers
(The TQCC of Seminars in Diagnostic Pathology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
EDITORIAL BOARD (p/u from previous issue)94
Pathology of hereditary renal cell carcinoma syndromes62
Update on selective special types of breast neoplasms: Focusing on controversies, differential diagnosis, and molecular genetic advances52
COVER (PMS 180&K) (p/u from previous issue w/updates)49
Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis38
TABLE OF CONTENTS (p/u from previous issue w/updates)34
The challenge of undifferentiated malignancies: Phenotype versus genotype! What matters most?29
EDITORIAL BOARD (p/u from previous issue)26
MASTHEAD (p/u from previous issue)25
Mucin-rich salivary gland tumors25
Spectrum of atypical ductal hyperplasia (ADH) and ductal carcinoma in-situ (DCIS): Diagnostic challenges21
Intraoperative evaluation of sentinel lymph nodes in patients with breast cancer: A review emphasizing clinical concepts pathologists need to know21
Salivary gland-like tumors of the breast: Histopathologic and genetic features with clinical implications20
Preface: An update on superficial mesenchymal tumors: How the explosion of data translates into every day clinical practice20
The current practice of telecytology for rapid on-site evaluation (ROSE): Practical considerations and limitations19
A personalized approach to lymphoproliferations in patients with inborn errors of immunity19
Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts18
Festschrift for Drs. Wick and Santa Cruz17
TABLE OF CONTENTS (p/u from previous issue w/updates)17
Head and neck xanthogranulomatous epithelial tumors/keratin-positive giant cell-rich tumors17
Molecular landscape of thymic epithelial tumors16
Primary cutaneous dedifferentiated and undifferentiated melanoma15
Frozen section evaluation of deceased donor kidney biopsies: A field guide14
Diagnostic clues and pitfalls in salivary gland fine-needle aspiration cytology14
Mimickers of immunoglobulin G4-related hepatobiliary disease on biopsy14
Targetoid hemosiderotic hemangioma: A review article14
The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰13
Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis13
Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis13
An adapted & improved validation protocol for digital pathology implementation12
MASTHEAD (p/u from previous issue)12
EDITORIAL BOARD (p/u from previous issue)11
MASTHEAD (p/u from previous issue)11
MASTHEAD (p/u from previous issue)11
“SMART” cytology: The next generation cytology for precision diagnosis10
Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis10
Navigating through perplex morphologic changes after exogenous hormone usage10
EDITORIAL BOARD (p/u from previous issue)10
Expanding the cytological and architectural spectrum of mucoepidermoid carcinoma: The key to solving diagnostic problems in morphological variants10
Indeterminate Thyroid Nodules and Advances in Molecular Pathology10
COVER (PMS 180&K) (p/u from previous issue w/updates)10
Molecular insights into hybrid tumors: Exploring the heterogeneity in plexiform ameloblastoma9
TABLE OF CONTENTS (p/u from previous issue w/updates)9
Cytogenetic and molecular aberrations at diagnosis and in prognosis of multiple myeloma9
MASTHEAD (p/u from previous issue)9
Benign and low-grade superficial endothelial cell neoplasms in the molecular era8
Appendiceal adenocarcinoma: Current concepts & challenges8
Well-differentiated neuroendocrine tumors of the appendix: Diagnosis, differentials, and disease progression8
Challenges and pitfalls in the diagnosis of IgG4-related disease8
Advances in cytology of lung cancer7
COVER (PMS 180&K) (p/u from previous issue w/updates)7
Review of immunohistochemistry techniques: Applications, current status, and future perspectives7
MASTHEAD (p/u from previous issue)7
COVER (PMS 180&K) (p/u from previous issue w/updates)6
Artificial intelligence for dermatopathology: Current trends and the road ahead6
Immunohistochemistry as predictive and prognostic markers for gastrointestinal malignancies6
Papillary lesions of the breast – review and practical issues6
Building an USGFNA clinic from scratch: A recipe from the USGFNA cookbook for successes6
Extrahepatic cholangiocarcinoma: Current concepts in histopathology, immunohistochemistry, and molecular diagnostics6
Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma6
COVER (PMS 180&K) (p/u from previous issue w/updates)6
Adenoid ameloblastoma revisited: A discursive exploration of its histological dualism, molecular aberrations, and clinical recurrence6
TABLE OF CONTENTS (p/u from previous issue w/updates)6
Recent updates in salivary gland tumors of the lung6
TABLE OF CONTENTS (p/u from previous issue w/updates)5
The thymus: General concepts on embryology, anatomy, histology and immunohistochemistry.5
Exploring the mysterious mucinous appendiceal neoplasm5
Update on sentinel node pathology in breast cancer5
Challenging differential diagnoses in small biopsies from the sinonasal tract5
EDITORIAL BOARD (p/u from previous issue)5
EDITORIAL BOARD (p/u from previous issue)5
Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques5
Acute mediastinitis, mediastinal granuloma, and chronic fibrosing mediastinitis: A review5
Differential diagnosis of multiple myeloma5
TABLE OF CONTENTS (p/u from previous issue w/updates)5
Thymoma: Histologically a heterogenous group of tumors5
Overdiagnosis of breast malignancy: Azzopardi's Problems in Breast Pathology revisited, Part I5
Immunohistochemical surrogates for molecular alterations for the classification and grading of gliomas5
Cytopathology assistance for optimizing interventional diagnostic procedures5
Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom5
0.20298099517822